The nanoparticles target a protein on tumor blood vessel cells called P-selectin and result in improved treatment of a model of aggressive pediatric brain cancer.
Lipid nanoparticles have been used to encapsulate CRISPR-Cas9 and deliver it to cells in mice, where it was highly effective at knocking down expression of a target protein.